Biotechnology News & Press Release Distribution

Biotechnology

APAC
Global

Catalent Appoints Nakaya Matsumaru as General Manager of its New Clinical Supply Facility in Shiga, Japan

SOMERSET, N.J., Dec. 14, 2020 /PRNewswire/ -- Catalent, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the appointment of Nakaya "N...

2020-12-14 10:28 4165

Catalent Appoints Nakaya Matsumaru as General Manager of its New Clinical Supply Facility in Shiga, Japan

Hope Medicine Inc. Announced Dr. Henri Nico Doods as President and Head of Research & Clinical Development

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed') is a global innovative biopharmaceutical company. HopeMed recently announced that the current Chairman of the Scientific Advisory Board, DrHenri Nico Doods, will serve as the company's President, as well as Head of Research & ...

2020-12-14 09:00 4872

Hope Medicine Inc. Announced Dr. Henri Nico Doods as President and Head of Research & Clinical Development

Seegene's aggregated sales surpass KRW 1 tril. this year and plans on expanding annual production capacity to KRW 5 tril. in 2021

SEOUL, South Korea, Dec. 13, 2020 /PRNewswire/ -- South Korea's biotechnology company specializing in molecular diagnosis, Seegene Inc. (KQ096530), announced Monday that its aggregated sales this year have already surpassed theKRW 1 trillion mark, up nearly 10 times its previous annual sales of K...

2020-12-14 07:30 4269

PharmaBlock Enters Strategic Partnership with Ascentage Pharma

NANJING, China, Dec. 11, 2020 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (300725.SZ), a leading innovative chemistry product and service provider throughout the pharmaceutical R&D process, announced the signing of a strategic partnership agreement with Ascentage Pharma (6855.HK), a glob...

2020-12-11 21:00 6369

European Union Intellectual Property Office Revokes Counterfeiter's Fake AQUAGOLD® Design Registration and Orders Payment to Aquavit of All Legal Fees and Costs

NEW YORK, Dec. 11, 2020 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") received a decision from the European Union Intellectual Property Office (EUIPO) today that it has revoked the counterfeiter U-BioMed's falsely registered AQUAGOLD® design, originally created and owned by Aquavit. ...

2020-12-11 03:10 2667

Global Biosimilars Market Poised to Grow at Chart-topping Levels with a CAGR of 17.3%, Reaching $79.2 Billion by 2026

With the third wave of biosimilars in the spotlight during the forecast period, revenues from the sensory organs market will dominate growth, finds Frost & Sullivan SANTA CLARA, Calif., Dec. 11, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Access to New Therapy Areas to Drive Major Gr...

2020-12-11 03:00 1591

DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor and positive impact of reference anti-HER2 treatment on overall survival

Results presented at the 2020 San Antonio Breast Cancer Symposium confirm the relevance of screening for HER2+ CTCs from blood samples in patients with a HER2 negative primary tumor biopsy to optimize treatment strategy and patient outcome BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 10, 2020...

2020-12-10 22:19 4189

INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China

PLYMOUTH MEETING, Pa. and SUZHOU, China, Dec. 10, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou Co., Ltd. ("...

2020-12-10 21:00 5052

ReCor Medical Announces Positive Results in RADIANCE-HTN TRIO Study and Breakthrough Device Designation for Paradise™ Ultrasound Renal Denervation System

PALO ALTO, Calif., Dec. 10, 2020 /PRNewswire/ -- ReCor Medical, Inc. ("ReCor"), a wholly-owned subsidiary of Otsuka Medical Devices, announced today that its Paradise™ Ultrasound Renal Denervation System (the "Paradise System") demonstrated positive results in the RADIANCE-HTN TRIO ("TRIO") study...

2020-12-10 16:01 1318

InDevR Expands Commercial Portfolio for Coronavirus Vaccine Characterization

BOULDER, Colo., Dec. 10, 2020 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Spike Protein Kit and SARS-CoV-2 Spike ...

2020-12-10 15:00 1063

Kazia to Collaborate with Pacific Pediatric Neuro-Oncology Consortium (PNOC) for New Paxalisib Combination Study in DIPG

SYDNEY, Dec. 10, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has executed a Letter of Intent with the Pacific Pediatric Neuro-Oncology Consortium (PNOC) to launch a clinical trial of...

2020-12-10 12:51 6095

PharmAbcine presents the latest data of the ongoing Phase Ib mTNBC trial at SABCS 2020

DAEJEON, South Korea, Dec. 9, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today the presentation of the latest interim data from its ongoing phase Ib combination trial of oli...

2020-12-09 23:00 1367

RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer

- First results from the independent SWOG Cancer Research Network-led Phase III study to be presented at the 2020 San Antonio Breast Cancer Symposium - RxPONDER results from over 5,000 women likely to transform the treatment of node-positive breast cancer, as the TAILORx study did in node-negativ...

2020-12-09 22:00 2734

Northway Biotechpharma, Biologics CDMO, Announces Company Brand Name Change to Northway Biotech

VILNIUS, Lithuania and WALTHAM, Mass., Dec. 9, 2020 /PRNewswire/ -- Northway Biotechpharma, providing end-to-end contract drug development and manufacturing (CDMO) services, announces brand name change toNorthway Biotech. Along with the tradename change, Dr. Vladas Algirdas Bumelis also returns t...

2020-12-09 21:39 1260

INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Anal Dysplasia Caused by HPV-16/18

PLYMOUTH MEETING, Pa., Dec. 9, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer and diseases associated with HPV, today announced positive Phase 2 efficacy ...

2020-12-09 21:00 3437

MiCAN Technologies' myeloid lineage cells help researchers fight COVID-19

KYOTO, Japan, Dec. 9, 2020 /PRNewswire/ -- MiCAN Technologies , a research service provider based in Kyoto Japan, revealed today that its human myeloid lineage cells[1] have been used to conduct research on the coronavirus SARS-CoV-2, which is responsible for ...

2020-12-09 20:49 1423

MiCAN Technologies' myeloid lineage cells help researchers fight COVID-19

HBM Holdings Limited Announces the Offer Price and Allotment Results of the Global Offering

This press release is NOT for release, publication, distribution, directly or indirectly, in or intothe United States (including its territories and possessions, any state ofthe United States and the District of Columbia) or any other jurisdiction where such distribution is prohibited by law. Thi...

2020-12-09 17:29 5838

Antengene Announces Collaboration with Applied BioMath, LLC for Systems Pharmacology Modeling in Oncology

SHANGHAI and HONG KONG, Dec. 9, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...

2020-12-09 08:00 3308

Top-line Final Data from Cantrixil Phase I Study Confirms Prior Positive Efficacy and Safety Signals

SYDNEY, Dec. 9, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share top-line final data from its phase I study of Cantrixil (TRX-E-002-1) in patients with persistent or recurrent ovarian cancer (NCT029...

2020-12-09 07:49 3201

Zelgen Selects Industry's First Automated, End-to-End Drug Safety System

Rapidly growing biopharma selects ArisGlobal's LifeSphere® MultiVigilance 10, benefits from industry's first cognitive automation and AI-enabled safety system, a game-changer for patient safety MIAMI, Dec. 9, 2020 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software that au...

2020-12-09 05:07 1743

1 ... 225 226 227228229 230 231 ... 279